专利检索 ap:("Centre Regional de Lutte Contre le Cancer D'Angers") AND inv:"GAMELIN, Laurence" 第 1 页

1.

发明授权
PROTECTION DE LA NEURITOXICITE DE L'OXALIPLATINE PAR ADMINISTRATION DE CALCIUM ET DE MAGNESIUM 有权
标题翻译：保护，禁止奥沙利铂通过施钙镁的神经毒性

公开(公告)号：EP1465642B1

公开(公告)日：2012-02-29

申请号：EP03712239.7

申请日：2003-01-14

申请人： Centre Regional de Lutte Contre le Cancer D'Angers

发明人： GAMELIN, Laurence , GAMELIN, Erick , BOISDRON-CELLE, Michèle , MOREL, Alain

IPC分类号： A61K33/06 , A61K33/10 , A61K31/7004 , A61P35/00

CPC分类号： A61K33/06 , A61K33/10 , A61K2300/00

摘要： The invention relates to products comprising calcium, injectable magnesium and an injectable product which releases oxalate during the metabolism thereof as a combination that can be used for simultaneous, sequential or separate administration in anticancer and antiviral therapies.

2.

发明公开
PROTECTION DE LA NEURITOXICITE DE L'OXALIPLATINE PAR ADMINISTRATION DE CALCIUM ET DE MAGNESIUM 有权
标题翻译：保护，禁止奥沙利铂通过施钙镁的神经毒性

公开(公告)号：EP1465642A1

公开(公告)日：2004-10-13

申请号：EP03712239.7

申请日：2003-01-14

申请人： Centre Regional de Lutte Contre le Cancer d'Angers

发明人： GAMELIN, Laurence , GAMELIN, Erick , BOISDRON-CELLE, Michèle , MOREL, Alain

IPC分类号： A61K33/06 , A61K33/10 , A61K31/7004 , A61P35/00

CPC分类号： A61K33/06 , A61K33/10 , A61K2300/00

摘要： The invention relates to products comprising calcium, injectable magnesium and an injectable product which releases oxalate during the metabolism thereof as a combination that can be used for simultaneous, sequential or separate administration in anticancer and antiviral therapies.